Загрузка...
Metabolic Dependencies in RAS-Driven Cancers
The ability to inhibit the RAS oncogene has been the holy grail of oncology because of the critical role of this gene in a multitude of tumor types. Additionally, RAS mutant tumors are amongst the most aggressive and refractory to treatment. While directly targeting the RAS oncogene has proven chall...
Сохранить в:
| Опубликовано в: : | Clin Cancer Res |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4400826/ https://ncbi.nlm.nih.gov/pubmed/25878364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2425 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|